Citius Oncology, Inc.Citius Oncology, Inc.Citius Oncology, Inc.

Citius Oncology, Inc.

No trades
See on Supercharts

Price target

3.000.000.00%
The 1 analyst offering 1 year price forecasts for CTOR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to CTOR in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CTOR EPS for the last quarter is −0.08 USD despite the estimation of −0.08 USD. In the next quarter EPS is expected to reach −0.06 USD. Track more of Citius Oncology, Inc. financials and stay on top of what is up with the company.
In the next quarter Citius Oncology, Inc. revenue is expected to reach 0.00 USD. Check out Citius Oncology, Inc. revenue and earnings and make informed decisions.
According to analysts, CTOR price target is 3.00 USD with a max estimate of 3.00 USD and a min estimate of 3.00 USD. Check if this forecast comes true in a year, meanwhile watch Citius Oncology, Inc. stock price chart and keep track of the current situation with CTOR news and stock market news.